You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

Portfolio Finder

Current Startups

TolerogenixX

TolerogenixX GmbH has developed a patented and clinically tested cell therapy technique for individualised immunosuppression in transplant patients. The technique enables the targeted disabling of undesired reactions caused by the immune system’s defences.

Info & Contact

Dr. Matthias Schaier
Phone:
+49 6221 5639930
Web:
www.tolerogenixx.com

Address

TolerogenixX GmbH
Im Neuenheimer Feld 162
69120 Heidelberg

Added to portfolio

21. Dec 2016